These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
624 related items for PubMed ID: 19443582
1. Quantification of inflammation within rabbit atherosclerotic plaques using the macrophage-specific CT contrast agent N1177: a comparison with 18F-FDG PET/CT and histology. Hyafil F, Cornily JC, Rudd JH, Machac J, Feldman LJ, Fayad ZA. J Nucl Med; 2009 Jun; 50(6):959-65. PubMed ID: 19443582 [Abstract] [Full Text] [Related]
2. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography. Zhao QM, Feng TT, Zhao X, Xu ZM, Liu Y, Li DP, Li LQ, Su G, Zhang XX. Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602 [Abstract] [Full Text] [Related]
3. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. Ogawa M, Magata Y, Kato T, Hatano K, Ishino S, Mukai T, Shiomi M, Ito K, Saji H. J Nucl Med; 2006 Nov; 47(11):1845-50. PubMed ID: 17079818 [Abstract] [Full Text] [Related]
4. Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging. Vucic E, Dickson SD, Calcagno C, Rudd JH, Moshier E, Hayashi K, Mounessa JS, Roytman M, Moon MJ, Lin J, Tsimikas S, Fisher EA, Nicolay K, Fuster V, Fayad ZA. JACC Cardiovasc Imaging; 2011 Oct; 4(10):1100-9. PubMed ID: 21999870 [Abstract] [Full Text] [Related]
5. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. J Nucl Cardiol; 2005 Oct; 12(3):294-301. PubMed ID: 15944534 [Abstract] [Full Text] [Related]
6. Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. Millon A, Dickson SD, Klink A, Izquierdo-Garcia D, Bini J, Lancelot E, Ballet S, Robert P, Mateo de Castro J, Corot C, Fayad ZA. Atherosclerosis; 2013 Jun; 228(2):339-45. PubMed ID: 23582588 [Abstract] [Full Text] [Related]
7. Multi-slice computed tomography with N1177 identifies ruptured atherosclerotic plaques in rabbits. Van Herck JL, De Meyer GR, Martinet W, Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van Der Veken P, Van Vaeck L, Bult H, Herman AG, Vrints CJ. Basic Res Cardiol; 2010 Jan; 105(1):51-9. PubMed ID: 19693628 [Abstract] [Full Text] [Related]
8. [The value of (18)F-fluorodeoxyglucose positron emission tomography-computed tomography ((18)F-FDG PET-CT) in evaluating the stability of atherosclerotic plaques]. Zhang YH, Tian P, Xu JP, Wang ZZ, Zhao XZ, Nie MX, Zhang MD, Zhao QM, Zhao BT, Song SJ. Zhonghua Nei Ke Za Zhi; 2019 Nov 01; 58(11):808-813. PubMed ID: 31665855 [Abstract] [Full Text] [Related]
9. (18)F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging study. Ogawa M, Ishino S, Mukai T, Asano D, Teramoto N, Watabe H, Kudomi N, Shiomi M, Magata Y, Iida H, Saji H. J Nucl Med; 2004 Jul 01; 45(7):1245-50. PubMed ID: 15235073 [Abstract] [Full Text] [Related]
10. Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor. Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, Fayad ZA. JACC Cardiovasc Imaging; 2018 Feb 01; 11(2 Pt 2):291-301. PubMed ID: 29413439 [Abstract] [Full Text] [Related]
11. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer 68Ga-Pentixafor for PET. Hyafil F, Pelisek J, Laitinen I, Schottelius M, Mohring M, Döring Y, van der Vorst EP, Kallmayer M, Steiger K, Poschenrieder A, Notni J, Fischer J, Baumgartner C, Rischpler C, Nekolla SG, Weber C, Eckstein HH, Wester HJ, Schwaiger M. J Nucl Med; 2017 Mar 01; 58(3):499-506. PubMed ID: 27789718 [Abstract] [Full Text] [Related]
12. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques. Silvola JM, Saraste A, Laitinen I, Savisto N, Laine VJ, Heinonen SE, Ylä-Herttuala S, Saukko P, Nuutila P, Roivainen A, Knuuti J. JACC Cardiovasc Imaging; 2011 Dec 01; 4(12):1294-301. PubMed ID: 22172786 [Abstract] [Full Text] [Related]
13. Monitoring of atherosclerosis evolution by detection of inflammatory states of aortae in a rabbit model using 18F-FDG -PET/CT. Zhao QM, Zhao X, Feng TT, Zhang MD, Zhuang XC, Zhao XC, Zhang XX, Su G. Q J Nucl Med Mol Imaging; 2014 Dec 01; 58(4):440-50. PubMed ID: 24518191 [Abstract] [Full Text] [Related]
14. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Laitinen I, Saraste A, Weidl E, Poethko T, Weber AW, Nekolla SG, Leppänen P, Ylä-Herttuala S, Hölzlwimmer G, Walch A, Esposito I, Wester HJ, Knuuti J, Schwaiger M. Circ Cardiovasc Imaging; 2009 Jul 01; 2(4):331-8. PubMed ID: 19808614 [Abstract] [Full Text] [Related]
15. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. Niccoli Asabella A, Ciccone MM, Cortese F, Scicchitano P, Gesualdo M, Zito A, Di Palo A, Angiletta D, Regina G, Marzullo A, Rubini G. Ann Nucl Med; 2014 Jul 01; 28(6):571-9. PubMed ID: 24737136 [Abstract] [Full Text] [Related]
16. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. Hetterich H, Rominger A, Walter L, Habs M, Volpers S, Hacker M, Reiser MF, Bartenstein P, Saam T. Int J Cardiovasc Imaging; 2016 Jan 01; 32(1):49-59. PubMed ID: 25898891 [Abstract] [Full Text] [Related]
17. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, Yates D, LaMuraglia GM, Furie K, Houser S, Gewirtz H, Muller JE, Brady TJ, Fischman AJ. J Am Coll Cardiol; 2006 Nov 07; 48(9):1818-24. PubMed ID: 17084256 [Abstract] [Full Text] [Related]
18. Variability and uncertainty of 18F-FDG PET imaging protocols for assessing inflammation in atherosclerosis: suggestions for improvement. Huet P, Burg S, Le Guludec D, Hyafil F, Buvat I. J Nucl Med; 2015 Apr 07; 56(4):552-9. PubMed ID: 25722452 [Abstract] [Full Text] [Related]
19. 18F-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: 18F-FDG accumulates in foamy macrophages. Ishino S, Ogawa M, Mori I, Nishimura S, Ikeda S, Sugita T, Oikawa T, Horiguchi T, Magata Y. Eur J Nucl Med Mol Imaging; 2014 Apr 07; 41(4):624-33. PubMed ID: 24258009 [Abstract] [Full Text] [Related]
20. FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. Davies JR, Izquierdo-Garcia D, Rudd JH, Figg N, Richards HK, Bird JL, Aigbirhio FI, Davenport AP, Weissberg PL, Fryer TD, Warburton EA. Int J Cardiovasc Imaging; 2010 Jan 07; 26(1):41-8. PubMed ID: 19784796 [Abstract] [Full Text] [Related] Page: [Next] [New Search]